Filing Details

Accession Number:
0001493152-24-047998
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-27 16:15:24
Reporting Period:
2024-11-19
Accepted Time:
2024-11-27 16:15:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1904286 Mira Pharmaceuticals Inc. MIRA Pharmaceutical Preparations (2834) 853354547
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1986112 Erez Aminov C/O Mira Pharmaceuticals, Inc.
1200 Brickell Ave. Suite 1950 #1183
Miami FL 33131
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-11-19 55,410 $1.39 1,105,790 No 4 S Direct
Common Stock Disposition 2024-11-20 44,590 $1.27 1,061,200 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transactions reported in this Form 4 were affected pursuant to a Rule 10b51 Trading Plan adopted by the Reporting Person on 8/20/2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions.